Skip to main content
. 2023 Apr 12;15:281–294. doi: 10.2147/CEOR.S404175

Figure 4.

Figure 4

The four reins are pulling back the adoption of biosimilars and artwork created by the Open AI platform, DALLE-2. (https://openai.com/product/dall-e-2).